HCV - Nonresponders / Relapsers / Re-treatment

HCV Polymerase Inhibitor R7128 Demonstrates Antiviral Activity in Prior Non-responders - 12/14/07

Three Studies Assess Consensus Interferon for Hepatitis C in Prior Non-responders, Relapsers and Patients with a High Likelihood of Treatment Failure    - 7/03/07

Safety and Tolerability of Peginterferon Alfa-2a (Pegasys)/Ribavirin in HCV Patients Non-Tolerant or Nonresponsive to Peginterferon Alfa-2b (PegIntron)/Ribavirin  - 5/25/07

Does Cognitive Function Worsen during Retreatment of Chronic Hepatitis C with Pegylated Interferon plus Ribavirin?  - 5/11/07

Adding Celgosivir to Standard Hepatitis C Therapy Increases the Likelihood of Early Response Rate in Prior Non-responders  - 4/20/07

Changes in Gene Expression during Hepatitis C Treatment Distinguish Responders from Non-Responders   2/20/07

Pegylated Interferon plus Ribavirin Failure: Is Re-treatment an Option?   2/20/07

Effect of Reducing Pegylated Interferon and Ribavirin Doses During Retreatment for Chronic Hepatitis C   - 2/09/07

Report of 6 Cases of Complete HCV Remission in Prior Non-Responders Treated with Pegylated Interferon Plus Ribavirin Plus Thalidomide  12/08/06

Pegylated Interferon Plus Ribavirin in Non-responders to Prior Interferon Therapy 11/17/06

Promising Data on Consensus Interferon Retreatment of Relapsers and Non-Responders - 6/09/06

Albuferon Demonstrates Promising Antiviral Activity in Prior Non-Responders - 6/09/06

CPG 10101: Promising Data at 12 Weeks in Prior Relapsers - 6/06/06


Retreatment with Peginterferon Alfa-2a (Pegasys) Plus Ribavirin of Nonresponders with Cirrhosis/Advanced Fibrosis to Peginterferon Alfa-2b (PegIntron) - 5/23/06

Interim Results of Studies of Albuferon plus Ribavirin in Nonresponders and in Treatment-naïve Patients with HCV Genotype 1 - 3/17/06